Hair Today, Gone Tomorrow? Supplements you haven't heard of, lab testing for telogen effluvium and managing folliculitis decalvans
Hair loss is common and devastating, both to the person losing their hair and the dermatology provider taking care of them. Derms on Drugs to the rescue. In part one of our deep dive into hair loss we cover three big topics: 1) What supplements for hair loss actually work? You'll have heard (ad nauseum) about some of them, but we'll also bring you some ideas for cheap supplements you haven't heard of that actually work; 2) Do we really need to do lab work-ups in patients with telogen effluvium? and 3) What's the state of the art when it comes to diagnosing and managing folliculitis decalvans? Join us for another episode with our trademark mix of evidence and banter! #DermatologyPodcast #HairLoss #DermsOnDrugs #AlopeciaProduced by ScholarsinMedicine.comScholarsinMedicine.com1. Management of folliculitis decalvans: The EADV task force on hair diseases position statement2. Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single-Center Experience3. Impact of Laboratory Work Up and Supplementation on Alopecia Patients: A Single-Center Retrospective Chart Review4. Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss A Systematic Review
--------
27:12
Nutrafol for Acne, Top Skin Care Ingredients, Hand Eczema Advances & More
Join Derms on Drugs for a must-hear episode packed with practical dermatology updates! Discover if Nutrafol Acne delivers, which skin care ingredients top cosmetic dermatologists swear by, and the latest breakthroughs for hand eczema. Plus, is Zoryve Foam a game-changer for psoriasis? And what’s the deal with PRAME staining for benign nevi? Get actionable insights to elevate your practice along with our usual banter. Derms on Drugs is produced by Scholars in Medicine.Resource links can be found at: Scholarsinmedicine.com1. A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial for the Efficacy and Safety of a Novel Nutraceutical for Mild-to-Moderate Acne2. Skincare Ingredients Recommended by Cosmetic Dermatologists: A Delphi Consensus Study3. Efficacy and safety of topical delgocitinib cream versus oral alitretinoin capsules in adults with severe chronic hand eczema (DELTA FORCE): a 24-week, randomised, head-to-head, phase 3 trial4. Oral roflumilast for the treatment of chronic hand eczema: a retrospective case series5. Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body6. Clinicopathologic Features of PRAME-Positive Common Melanocytic Nevi: A Case-Control Study
--------
46:12
Why Are Dermatology Drugs So Expensive?
Skyrocketing drug prices are hitting dermatology hard. Why are Americans paying more than other countries? Are Pharmacy Benefit Managers (PBMs) or pharmaceutical companies to blame? Join Derms on Drugs as our experts pull back the curtain on the broken system driving costs. Get insider insights, practical takeaways, and our trademark banter to navigate this mess as a clinician.Derms on Drugs is a production of Scholarsinmedicine.com1. Use and Cost of First-Line Biologic Medications to Treat Plaque Psoriasis in the US2. Systematic review and estimated cost-efficacy of biologics compared with narrowband ultraviolet B light for the treatment of moderate to severe psoriasis and atopic dermatitis3. AI Description and Answers About How Drug Pricing WorksScholarsinmedicine.com
--------
1:06:40
Man vs Machine - Are computers and AI going to replace dermatologists?
Join Derms on Drugs for a riveting dive into artificial intelligence and automated skin cancer detection. World-renowned expert Dr. Laura Ferris, with 20 years in the field, breaks down cutting-edge research and predicts the future of dermatology. Will AI "terminate" dermatologists or empower us to focus on complex cases and patient care? Expect fresh insights, practical takeaways, and lively banter that’ll make you a smarter clinician. Don’t miss this chance to stay ahead in the AI revolution!Derms on Drugs is produced by Scholars In MedicineFor Resources links visit: Scholars In Medicine1. Diagnostic performance of augmented intelligence with 2D and 3D total body photography and convolutional neural networks in a high-risk population for melanoma under real-world conditions: A new era of skin cancer screening?2. 3D Total-Body Photography in Patients at High Risk for Melanoma3. Promises and Pitfalls of 3D Total-Body Photography for Melanoma Early Detection4. Real-world post-deployment performance of a novel machine learning-based digital health technology for skin lesion assessment and suggestions for post-market surveillance5. Standard Dermatoscope Images vs an Autonomous Total Body Photography and Dermoscopic Imaging Device
--------
56:16
Melanoma, Pre-Menstrual Rashes, Dermatomyositis and more
Tune in to Derms on Drugs for a the most fun you can have while diving into the hottest dermatology topics! This week, we unpack cutting-edge insights from the latest literature to make you a sharper clinician. Explore adjuvant therapy for Stage 3A melanoma, the pitfalls of dermatomyositis misdiagnosis, and a surprising finding: is hydroxychloroquine outperforming NBUVB for vitiligo? Plus, discover new skin-gut-immune connections, tackle cancer immunotherapy-induced pemphigoid, and learn how to manage premenstrual rash flares in atopic dermatitis, contact dermatitis, and autoimmune progesterone dermatitis. Join our fun, banter-filled discussion to stay ahead in dermatology!In This Episode:Stage 3A Melanoma: Is adjuvant therapy worth it, and what’s the best option?Dermatomyositis: Consequences of misdiagnosis and delayed diagnosisVitiligo: Could hydroxychloroquine be a game-changer over NBUVB?Skin Inflammation: A key driver of food allergyPemphigoid: Insights into immunotherapy-induced casesPremenstrual Rashes: Managing flares in atopic1. Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.2. Patterns and Clinical Implications of Misdiagnosis in Dermatomyositis3. Effectiveness, Tolerability and Safety of Topical Clobetasol with Oral Hydroxychloroquine versus Topical Clobetasol with NBUVB Phototherapy in Unstable Vitiligo: Investigator Blind, Randomized Controlled Trial4. Skin damage signals mediate allergic sensitization to spatially unlinked antigen5. Epitope Spreading in Immune Checkpoint Inhibitor–Associated Bullous Pemphigoid6. The impact of the menstrual cycle on exacerbations of atopic dermatitis: a systematic review7. Nickel contact allergy and menstrual cycle8. Autoimmune progesterone dermatitis: Update and insightsDerms on Drugs is produced by Scholars in Medicine.com
Derms on Drugs is where cutting-edge dermatology meets mediocre comedy. Each week three dermatologists – Matt Zirwas, Laura Ferris and Tim Patton – discuss, debate, and dissect the hottest topics in dermatology.
It's everything you need to know to be on the cutting-edge of dermatology and it’ll be the most fun you’ve ever had while actually learning something useful.
Derms on Drugs is produced by Scholars in Medicine, an online educational platform (scholarsinmedicine.com) exclusively for healthcare professionals of all levels of experience and education.
Ireland